Business Wire

LabGenius Appoints Dr. Gino Van Heeke as Chief Scientific Officer

Share

LabGenius, the machine learning (ML)-driven protein engineering company, today announced the appointment of Gino Van Heeke Ph.D. as Chief Scientific Officer (CSO). In this role, Gino will leverage his wealth of drug discovery and development experience to direct LabGenius’ scientific strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211129005436/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Dr. Gino Van Heeke Appointed as LabGenius' CSO (Photo: Business Wire)

“I’m extremely pleased to welcome Gino to the company as CSO,” said Dr. James Field, Founder and CEO of LabGenius. “Gino is an accomplished scientific leader with an impressive track record of successfully advancing drug candidates into pre-clinical and clinical development.”

Gino joins LabGenius from Engitix Therapeutics, where, as CSO, he established a portfolio of projects and initiated the company’s first drug discovery campaign. Before this, Gino was Senior Director, Discovery and Early Development at Ablynx where he led the discovery of NANOBODY® drug candidates and their transition to clinical development. Prior to his move into biotech, Gino held several senior positions at Novartis Institutes for Biomedical Research over a 22-year tenure, including Executive Director for Biologics.

Speaking about his appointment, Dr. Gino Van Heeke said, “The ML-driven protein engineering platform that the team at LabGenius has expertly built presents a tremendous opportunity to revolutionize the way in which drugs are discovered. With solid foundations in place, I am delighted to join the company and apply my drug discovery knowledge and experience to ensure we use our unique platform in the most effective way possible.”

Dr. Edwin Moses, LabGenius Chairman commented “Gino’s expertise in translational research, coupled with LabGenius’ ML-driven drug discovery platform, is an excellent combination which I believe will further accelerate the company’s successful development.”

– end –

About LabGenius

LabGenius is a leading ML-driven protein engineering company, accelerating the discovery of novel therapeutics through the co-optimization of therapeutically valuable properties. The company’s discovery platform, EVATM, integrates several cutting-edge technologies drawn from the fields of computer science, robotic automation and synthetic biology. Headquartered in London, UK, the LabGenius team includes experts in protein engineering, synthetic biology, software engineering, data science and robotic automation.

For more information, please visit www.labgeni.us, or connect on Twitter, Facebook, and LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information, please contact:
Media enquiries:
Communications Lead
Lucy Shaw
press@labgeni.us

Business development:
Chief Operating Officer
Didier Landais
didier.landais@labgeni.us

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sweden Achieves the Lowest Smoking Rate in Europe and is on Track to Become Officially Smoke-Free - The EU Must Take Note6.12.2022 08:01:00 CET | Press release

Swedish authorities officially confirmed that the current level of smoking in Sweden has fallen to 5,6%. This makes Swedes the only European nation close to reaching the smoke-free goal set by the EU 18 years ahead of the 2040 target. In an event organised by the Oral Nicotine Commission in Stockholm, participants took stock of Sweden’s incredible achievements and leadership in the race to end smoking. It is about to become the first country in the world to be defined as “smoke free”, representing a share of less than 5% of the population smoking. Sweden’s smoking rates have shot down since the 1980s from 35% down to below 6% - a feat that is yet to be replicated by any other nation in the world. The next lowest smoking rate in Europe is double that of Sweden’s, with the EU average sitting somewhere around 23%, four times higher than in Sweden. The result is the lowest tobacco mortality rate in Europe. A group of leading public health professionals, consumer advocates and harm reductio

Thales Reinforces its Border & Travel Offer With the New Multimodal Biometric Pod6.12.2022 08:00:00 CET | Press release

The new Thales multimodal biometric pod is an efficient enrolment and identification solution that helps smoothly manage travelers’ border and immigration processes. The combination of ‘iris & face’ capture and recognition capacities enables a fast and secure enrolment and ID verification at borders. The pod features a modern design that perfectly suits the authority’s needs in highly secure environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221205005072/en/ (Photo: Thales) The travel industry and border security agencies have recognized the need to improve efficiency and overall traveler experience at border entry and exit points. For years, biometrics has been used by authorities to simplify traveler experiences at borders, speeding up people enrolment and ID checks such as the eGates or Entry-Exit Systems. With the Thales multimodal biometric pod, borders authorities can easily integrate automation into their pr

Ageras Launches Small-Biz Inflation Tracker, Finds Inflation Rates Outpacing Prices Charged by Europe’s Smallest Businesses6.12.2022 08:00:00 CET | Press release

Ageras, the leading fintech company utilizing its banking and accounting software to power more than one million small businesses across Europe and the United States, announced today that it launched its proprietary Inflation Tracker, revealing how the rise in the Consumer Price Index dramatically outpaced the rise in prices billed by Europe’s small businesses across seven Western European economies in the most recent quarter. By comparing how much tens of thousands of freelancers, microbusinesses, and other SMEs raised the prices for the same set of goods via Ageras’ accounting software between July through September versus the rise in each country’s official Consumer Price Index, Ageras data provides insight into how the smallest business owners across some of Europe’s largest economies are faring relative to overall inflation rates. “We launched our index because we wanted to objectively study and highlight the unique challenges facing the economy's unsung heroes — sole proprietors

Saudi Space Commission announces launch of Saudi Space Accelerator Program5.12.2022 15:52:00 CET | Press release

Saudi Space Commission announces the launch of its Saudi Space Accelerator Program in line with the Kingdom's vision of becoming a global hub of innovation by 2030. The program seeks to enhance the national Space sector through the development of its infrastructure and enabling local entrepreneurs and businesses to advance innovative Space solutions. The Program addresses the current state in the Kingdom's Space sector and proposes proactive Space solutions. Through the implementation of this program, the commission will ignite the local ecosystem and determine its maturity level, and to ensure that the sector remains viable for years to come, by providing an established business environment for growth and innovation for entrepreneurs to thrive in – overall improving the effectiveness of the commission's future programs and initiatives over the long-run. The Saudi Space Accelerator Program is being supported by a greater initiative; The future Office for Entrepreneurship Development, t

Advent Technologies Completes Fuel Cell Project for the European Space Agency5.12.2022 15:00:00 CET | Press release

Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent“ or the “Company”), an innovation-driven leader in the fuel cell and hydrogen technology space, today announced the successful completion of a research and development project commissioned under a programme of and funded by the European Space Agency (“ESA”), dedicated to the development of a closed-loop regenerative fuel cell system (“RFCS”) earlier this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221205005299/en/ The project started in 2014, with Advent as the prime contractor. Subcontractors included the Centre for Research and Technology – Hellas, the Foundation for Research and Technology – Hellas, and the University of Patras. The project concluded with the successful delivery of the high-temperature proton exchange membrane (“HT-PEM”) stack to ESA. During a highly successful testing phase, the RFCS demonstrated its ability to effectively meet the power

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom